Arno Therapeutics
Signal active
Organization
Contact Information
Overview
Arno Therapeutics is a biopharmaceutical company focused on creating value through the development of innovative products for the treatment of cancer patients.
About
Industries
Biotechnology, Medical, Biopharma
Founded
2000
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Arno Therapeutics headquartered in United States, North America, operates in the Biotechnology, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $2.9B in funding across 48 round(s). With a team of 11-50 employees, Arno Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Arno Therapeutics, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$61.4M
Details
0
Arno Therapeutics has raised a total of $61.4M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Arno Therapeutics is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Commercial Street Capital | - | FUNDING ROUND - Commercial Street Capital | 8.0M |
| Arno Therapeutics | - | FUNDING ROUND - Arno Therapeutics | 8.0M |
| Bonderman Family Limited Partnership | - | FUNDING ROUND - Bonderman Family Limited Partnership | 8.0M |
| Arno Therapeutics | - | FUNDING ROUND - Arno Therapeutics | 31.0M |
Recent Activity
There is no recent news or activity for this profile.